当前位置: X-MOL首页全球导师 国内导师 › 贺利贞

个人简介

10/2020-至今,研究员,暨南大学附属第一医院 11/2018-09/2020,副研究员,暨南大学化学与材料学院 07/2017-09/2020,博士后,暨南大学生物医学工程 09/2013-06/2016,博士,暨南大学细胞生物学 09/2011-06/2013,硕士,暨南大学化学系 09/2007-06/2011,学士,湖南理工学院化学系

研究领域

本人一直从事化学生物学与纳米医学的教学与科研工作,主要研究方向:靶向纳米药物的功能化设计与合成,并探究其在肿瘤、神经系统、骨相关疾病及其他慢性疾病的诊断与治疗中的应用机制

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Lizhen He#, Guanning Huang#, Hongxing Liu, Chengcheng Sang, Xinxin Liu and Tianfeng Chen*. Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke, Science Advances, 2020, 6: eaay9751. (影响因子12.804,ESI高被引) Lizhen He, Jianfu Zhao, Hongjun Li, Bin Xie, Ligeng Xu, Guanning Huang, Ting Liu, Zhen Gu*, Tianfeng Chen*, Metabolic reprogramming of NK cells by black phosphorus quantum dots potentiates cancer immunotherapy, Advanced Science, 2023, 10 (8): 2202519. (影响因子17.521) Zushuang Xiong#, Hao Lin#, Hong Li, Binghua Zou, Bin Xie, Yanzi Yu, Lizhen He*, Tianfeng Chen*. Chiral Selenium Nanotherapeutics Regulates Selenoproteins to Attenuate Glucocorticoid-induced Osteoporosis,Advanced Functional Materials. 2023,DOI: 10.1002/adfm.202212970 ((影响因子19.924) Zhuo Wang‡, Lizhen He‡(co-first author), Bingqing Liu, Li-Peng Zhou, Li-Xuan Cai, Shao-Jun Hu, Xiao-Zhen Li, Zhikai Li, Tianfeng Chen,* Xiaopeng Li,* Qing-Fu Sun*. Coordination-Assembled Water-Soluble Anionic Lanthanide Organic Polyhedra for Luminescent Labeling and Magnetic Resonance Imaging. J. Am. Chem. Soc., 2020, 142(38), 16409-16419. (影响因子14.612) Wei Huang, Lizhen He*, Zhongyang Zhang, Sujiang Shi, and Tianfeng Chen*. Shape-Controllable Tellurium-Driven Heterostructures with Activated Robust Immunomodulatory Potential for Highly Efficient Radiophotothermal Therapy of Colon Cancer, ACS Nano, 2021, 15, 12, 20225–20241 (影响因子15.881) Zhongwen Yuan#, Xinxin Liu#, Jiabao Ling, Guanning Huang, Jiarun Huang, Xueqiong Zhu, Lizhen He*, Tianfeng Chen*. In situ- transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis. Biomaterials, 2022, 287, 121620.(A1 1区,IF= 15.304) 共同通讯 Binhua Zou#, Zushuang Xiong#, Lizhen He*, Tianfeng Chen*. Reversing Breast Cancer Bone Metastasis by Metal Organic Framework-Capped Nanotherapeutics via Suppressing Osteoclastogenesis. Biomaterials, 2022, 285, 121549. (A1 1区,IF= 15.304) 共同通讯 Qi Chen#, Lizhen He#, Xiaoying Li, Ligeng Xu* and Tianfeng Chen*. Ruthenium Complexes Boost NK Cell Immunotherapy via Sensitizing Triple-negative Breast Cancer and Shaping Immuno-microenvironment. Biomaterials, 2022, 281, 121371. (A1 1区,IF= 15.304) 共同一作 Guanning Huang#, Jiankun Zang#, Lizhen He#, Huili Zhu#, Jiarun Huang, Zhongwen Yuan, Tianfeng Chen*, Anding Xu*. Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke, ACS Nano, 2022, 16, 1, 431–452.(影响因子15.881) Jiabao Ling#, Yanzhou Chang#, Zhongwen Yuan, Qi Chen, Lizhen He*, Tianfeng Chen*. Designing Lactate Dehydrogenase- Mimicking SnSe Nanosheets to Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. ACSApp. Mater. Interfaces, 2022, 14 (24), 27651. (A1 1区,IF= 10.383) 共同通讯 Xiaoying Li#, Yanzi Yu#, Qi Chen, Jiabao Lin, Xueqiong Zhu, Xiaoting Liu, Lizhen He*, Tianfeng Chen, Weiling He*,Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer. J. Nanobiotechnol. 2022, doi.org/10.1186/s12951-022-01593-5. (A1 1区,IF= 9.429) 共同通讯 Lizhen He#, Tianqi Nie#, Xiaojun Xia, Ting Liu, Yanyu Huang, Xiaojuan Wang, Tianfeng Chen*. Designing Bioinspired 2D MoSe2 Nanosheet for Efficient Photothermal-Triggered Cancer Immunotherapy with Reprogramming Tumor-associated Macrophages. Adv. Funct. Mater.2019, 1901240. (封面文章,影响因子15.621) Hongxing Liu, Weiqiang Lin, Lizhen He*, Tianfeng Chen*. Radiosensitive Core/Satellite Ternary Heteronanostructure for Multimodal Imaging-Guided Synergistic Cancer Radiotherapy. Biomaterials, 2020, 226, 119545. (影响因子15.304,ESI高被引) Mai, Xiaoxuan#; Chang, Yanzhou#; You, Yuanyuan; He, Lizhen*; Tianfeng Chen*, Designing Intelligent Nano-bomb with On-demand Site-specific Drug Burst Release to Synergize with High-Intensity Focused Ultrasound Cancer Ablation, Journal of Controlled Release, 2021, 331, 270-281. (DOI: 10.1016/j.jconrel.2020.09.051) (影响因子11.467) Haoqiang Lai#, Xiaobin Zhang#, Zhenhuan Song, Zhongwen Yuan, Lizhen He⁎, Tianfeng Chen⁎. Facile synthesis of antioxidative nanotherapeutics using a microwave for efficient reversal of cisplatin-induced nephrotoxicity. Chemical Engineering Journal, 2020, 123563. (影响因子16.744) Lizhen He#, Li-Xuan Cai#, Meng-Hua Li, Guang-Lu Zhang, Li-Peng Zhou, Tianfeng Chen*, Mei-Jin Lin* and Qing-Fu Sun*. Designing a highly stable coordination-driven metallacycle for imaging-guided photodynamic cancer theranostics, Chemical Science, 2020, 11, 7940-7949. (影响因子9.346) Xiaoying Li#, Xiaoming Guo#, Jiabao Ling, Zheng Tang, Guanning Huang, Lizhen He*, Tianfeng Chen*, Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages, Nanoscale, 2021, 13, 4705. (影响因子6.895) Lizhen He, Tianfeng Chen*, Yuanyuan You, Hao Hu, Wenjie Zheng, Wai-Lun Kwong, Taotao Zou and Chi-Ming Che*. A Cancer-Targeted Nanosystem for Delivery of Anti-Cancer Gold(III) Complexes: Enhanced Selectivity and Apoptosis-Inducing Efficacy of Gold(III) Porphyrin. Angew Chem Int Edit, 2014, 53(46), 12532-12536.(影响因子12.102) Hao Huang#, Lizhen He# (co-first author), Wenhua Zhou, Guangbo Qu, Jiahong Wang, Na Yang, Jie Gao, Tianfeng Chen*, Paul K. Chu and Xue-Feng Yu*. Stable Black Phosphorus/Bi2O3 Heterostructures for Synergistic Cancer Radiotherapy. Biomaterials, 2018, 171, 12-22. (影响因子15.304) Jianbin Mo#, Lizhen He# (co-first author), Bin Ma, Tianfeng Chen*. Tailoring Particle Size of Mesoporous Silica Nanosystem to Antagonize Glioblastoma and Overcome Blood-brain Barrier. ACS Applied Materials & Interfaces, 2016, 8 (11), pp 6811–6825. (影响因子 10.383)

推荐链接
down
wechat
bug